Your browser version may not work well with NCBI's Web applications. More information here...
1: Genome Biol. 2005;6(13):243. Epub 2005 Dec 23.Click here to read Click here to read Links

New approaches to combating antimicrobial drug resistance.

Avison MB.

Department of Cellular and Molecular Medicine, Bristol Centre for Antimicrobial Research and Evaluation, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK. Matthewb.Avison@bristol.ac.uk

Recent work shows that the inhibition of the SOS stress response in Escherichia coli reduces the development of resistance to the antibiotics ciprofloxacin and rifampicin. This finding may help in the battle against the rise of resistance to antimicrobial drugs.

PMID: 16420675 [PubMed - indexed for MEDLINE]

PMCID: PMC1414098

Patient Drug Information

  • Ciprofloxacin (Cipro® , Cipro® XR, Proquin® XR)

    Ciprofloxacin is used to treat or prevent certain infections caused by bacteria. Ciprofloxacin is also used to treat or prevent anthrax (a serious infection that may be spread on purpose as part of a bioterror attack) in...

  • Source: AHFS Consumer Medication Information